THE SCIENTIFIC BASIS OF MEDICAL THERAPY OF ACUTE PANCREATITIS
- 1 September 1999
- journal article
- review article
- Published by Elsevier in Gastroenterology Clinics of North America
- Vol. 28 (3) , 591-599
- https://doi.org/10.1016/s0889-8553(05)70075-3
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Sodium fusidate and the cytokine response in an experimental model of acute pancreatitisBritish Journal of Surgery, 1998
- A monoclonal anti-interleukin 8 antibody (WS-4) inhibits cytokine response and acute lung injury in experimental severe acute necrotising pancreatitis in rabbitsGut, 1998
- Prospective placebo-controlled randomized trial of lexipafant in predicted severe acute pancreatitisBritish Journal of Surgery, 1997
- Randomized, double-blind phase II trial of Lexipafant, a platelet-activating factor antagonist, in human acute pancreatitisBritish Journal of Surgery, 1995
- Amelioration of experimental acute pancreatitis with a potent platelet-activating factor antagonistBritish Journal of Surgery, 1994
- Role of platelet activating factor in acute pancreatitis induced by lipopolysaccharides in rabbitsEuropean Journal of Pharmacology, 1994
- Role of platelet activating factor in pathogenesis of acute pancreatitis in rats.Gut, 1992
- lnterleukin‐8 and neutrophil activation in acute pancreatitisEuropean Journal of Clinical Investigation, 1992
- Multicentre clinical trial of low volume fresh frozen plasma therapy in acute pancreatitisBritish Journal of Surgery, 1987
- A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitisBritish Journal of Surgery, 1978